- JP-listed companies
- Vitabrid Japan Inc.
- Financials
- Research & development
Vitabrid Japan Inc. (542A)
Market cap
¥5.9B
P/E ratio
8x
Vitabrid Japan makes health and beauty supplements sold directly to consumers online, with their sugar and fat-blocking supplement Terminalia First driving most sales.
| Period End | Research & development (Million JPY) | YoY (%) |
|---|